OSCR.N Relative Valuation
OSCR.N's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OSCR.N is overvalued; if below, it's undervalued.
Historical Valuation
Oscar Health Inc (OSCR.N) is now in the Fair zone, suggesting that its current forward PS ratio of 0.35 is considered Fairly compared with the five-year average of 25.52. The fair price of Oscar Health Inc (OSCR.N) is between 16.22 to 20.10 according to relative valuation methord.
Relative Value
Fair Zone
16.22-20.10
Current Price：16.77
Fair
-32.30
PE
1Y
3Y
5Y
Trailing
Forward
-394.52
EV/EBITDA
Oscar Health Inc. (OSCR.N) has a current EV/EBITDA of -394.52. The 5-year average EV/EBITDA is -10.16. The thresholds are as follows: Strongly Undervalued below -131.50, Undervalued between -131.50 and -70.83, Fairly Valued between 50.51 and -70.83, Overvalued between 50.51 and 111.19, and Strongly Overvalued above 111.19. The current Forward EV/EBITDA of -394.52 falls within the Strongly Undervalued range.
-50.31
EV/EBIT
Oscar Health Inc. (OSCR.N) has a current EV/EBIT of -50.31. The 5-year average EV/EBIT is 2.05. The thresholds are as follows: Strongly Undervalued below -27.96, Undervalued between -27.96 and -12.95, Fairly Valued between 17.05 and -12.95, Overvalued between 17.05 and 32.06, and Strongly Overvalued above 32.06. The current Forward EV/EBIT of -50.31 falls within the Strongly Undervalued range.
0.35
PS
Oscar Health Inc. (OSCR.N) has a current PS of 0.35. The 5-year average PS is 0.50. The thresholds are as follows: Strongly Undervalued below -0.52, Undervalued between -0.52 and -0.01, Fairly Valued between 1.01 and -0.01, Overvalued between 1.01 and 1.52, and Strongly Overvalued above 1.52. The current Forward PS of 0.35 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Oscar Health Inc. (OSCR.N) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.49. The thresholds are as follows: Strongly Undervalued below -68.15, Undervalued between -68.15 and -37.32, Fairly Valued between 24.35 and -37.32, Overvalued between 24.35 and 55.18, and Strongly Overvalued above 55.18. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-12.08
P/FCF
Oscar Health Inc. (OSCR.N) has a current P/FCF of -12.08. The 5-year average P/FCF is 3.16. The thresholds are as follows: Strongly Undervalued below -44.15, Undervalued between -44.15 and -20.50, Fairly Valued between 26.82 and -20.50, Overvalued between 26.82 and 50.48, and Strongly Overvalued above 50.48. The current Forward P/FCF of -12.08 falls within the Historic Trend Line -Fairly Valued range.
Oscar Health Inc (OSCR.N) has a current Price-to-Book (P/B) ratio of 4.28. Compared to its 3-year average P/B ratio of 2.93 , the current P/B ratio is approximately 46.17% higher. Relative to its 5-year average P/B ratio of 2.36, the current P/B ratio is about 81.53% higher. Oscar Health Inc (OSCR.N) has a Forward Free Cash Flow (FCF) yield of approximately 16.59%. Compared to its 3-year average FCF yield of 12.83%, the current FCF yield is approximately 29.35% lower. Relative to its 5-year average FCF yield of 10.21% , the current FCF yield is about 62.54% lower.
4.28
P/B
Median3y
2.93
Median5y
2.36
16.59
FCF Yield
Median3y
12.83
Median5y
10.21
Competitors Valuation Multiple
The average P/S ratio for OSCR.N's competitors is 0.43, providing a benchmark for relative valuation. Oscar Health Inc Corp (OSCR.N) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of OSCR.N increased by 24.78% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.24 to -4.60.
The secondary factor is the Revenue Growth, contributed 23.21%to the performance.
Overall, the performance of OSCR.N in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Oscar Health Inc (OSCR.N) currently overvalued or undervalued?
What is Oscar Health Inc (OSCR.N) fair value?
How does OSCR.N's valuation metrics compare to the industry average?
What is the current P/B ratio for Oscar Health Inc (OSCR.N) as of Dec 08 2025?
What is the current FCF Yield for Oscar Health Inc (OSCR.N) as of Dec 08 2025?
What is the current Forward P/E ratio for Oscar Health Inc (OSCR.N) as of Dec 08 2025?